Back to DE Deerfield Management Company, L.P.
XLRN
Showing 0 of 9 quarters
Position history for DEDeerfield Management Company, L.P.'s holdings in ACCELERON PHARMA INC
As of its Q3 2021 13F, Deerfield Management held 145,000 shares of XLRN (Acceleron Pharma), worth $25M. Deerfield Management listed XLRN in 8 quarterly 13F filings through Q3 2021. XLRN was 0.5% of Deerfield Management's reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
—
No position history available for this security.
Other major holders of XLRN: T. Rowe Price Associates, Inc., FMR LLC, Avoro Capital Advisors LLC